At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Self-management of Heparin Therapy - Drug Use Problems and Compliance With Self-injected Low Molecular Weight Heparin in Ambulatory Care
In Brief
A Phase 4 clinical trial evaluating patient education for Thromboembolism. Completed, enrolled 154 participants across 2 sites.
Detailed Summary
There is very little data available on compliance with self-injected low molecular weight heparins (LMWH), but what there is, definitely shows that compliance represents a significant problem. We therefore aim to a) record drug use problems of patients including compliance, b) develop a "SOP" for first instruction by a pharmacist and for subsequent pharmaceutical care and c) to compare intensive pharmaceutical care (intervention) vs. standard care (control) provided in the pharmacy to patients with a prescription for a LMWH as an outpatient treatment. Hypothesis: Intensive pharmaceutical care in ambulatory patients who self-inject low molecular weight heparins results in improved compliance, more safety and satisfaction as well as in fewer complications.
Study Details
Timeline
Interventions
Possible, individualized interventions: * Improvement of patient's knowledge about medication, therapy and drug application by providing detailed written information material * Providing a complete equipment package for self-injection (disinfection patches, patches, plasters, waste disposal box for used syringes) * Patient training: oral instructions for self-injection (and application, if required), exercising the injection technique on a phantom * First self-injection under control of a specially trained pharmacist